Financial Avengers’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$52.3K Sell
100
-20
-17% -$10.2K 0.02% 60
2026
Q2
$59.6K Sell
120
-5
-4% -$2.22K 0.02% 57
2026
Q1
$55.8K Hold
125
– – 0.03% 56
2025
Q4
$56.7K Hold
125
– – 0.02% 60
2025
Q3
$49K Sell
125
-15
-11% -$6.27K 0.02% 64
2025
Q2
$62.3K Hold
140
– – 0.03% 54
2025
Q1
$67.9K Sell
140
-10
-7% -$4.66K 0.03% 55
2024
Q4
$60.4K Hold
150
– – 0.03% 60
2024
Q3
$69.8K Hold
150
– – 0.03% 58
2024
Q2
$70.3K Hold
150
– – 0.04% 51
2024
Q1
$63.1K Hold
150
– – 0.03% 53
2023
Q4
$61K Hold
150
– – 0.04% 52
2023
Q3
$52.2K Hold
150
– – 0.03% 53
2023
Q2
$52.8K Sell
150
-50
-25% -$16.8K 0.03% 53
2023
Q1
$63K Hold
200
– – 0.05% 48
2022
Q4
$57.8K Hold
200
– – 0.05% 48
2022
Q3
$58K Sell
200
-50
-20% -$14.4K 0.05% 45
2022
Q2
$70K Sell
250
-100
-29% -$26.8K 0.06% 44
2022
Q1
$91K Hold
350
– – 0.06% 44
2021
Q4
$77K Sell
350
-50
-13% -$9.7K 0.05% 50
2021
Q3
$73K Hold
400
– – 0.05% 51
2021
Q2
$81K Sell
400
-361
-47% -$75.5K 0.05% 48
2021
Q1
$164K Sell
761
-4
-0.5% -$879 0.12% 31
2020
Q4
$181K Buy
+765
New +$176K 0.15% 24

Other funds holding VRTX

Financial Avengers's VRTX Position: Q3 2026 in Review

Financial Avengers reduced its Vertex Pharmaceuticals (VRTX) stake by 17% in Q3 2026, selling an estimated $10.2K and leaving 100 shares worth $52.3K. The position accounts for 0.02% of the portfolio, ranked #60.

Financial Avengers first reported a position in VRTX in Q4 2020 and has held it in 24 quarters since. The position peaked at $181K in Q4 2020. 1,798 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Financial Avengers held 100 shares of Vertex Pharmaceuticals worth $52.3K as of Q3 2026.
  • Financial Avengers sold 20 Vertex Pharmaceuticals shares in Q3 2026, an estimated $10.2K.
  • Vertex Pharmaceuticals made up 0.02% of Financial Avengers's portfolio in Q3 2026, its #60 holding.
  • Financial Avengers first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
  • Financial Avengers's Vertex Pharmaceuticals position peaked at $181K in Q4 2020.
  • 1,798 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Financial Avengers's 13F filing for Q3 2026, filed 16 Nov 2026.